Azra AI Launches Groundbreaking Patient Journey Module for Comprehensive Cancer Patient Tracking

Newest AI-powered Patient IntelligenceTM module is the first all-in-one care management application to track the progress of cancer patients from diagnosis through aftercare


FRANKLIN, Tenn.–(BUSINESS WIRE)–Azra AI, a healthtech leader that provides artificial intelligence (AI) and workflow automation tools to accelerate the identification and treatment of cancer, is proud to announce the launch of its groundbreaking Patient Journey module. This cutting-edge addition to the Azra AI suite empowers hospitals and healthcare providers to seamlessly track a patient’s progress from cancer diagnosis through aftercare, all in one convenient place, through our state-of-the-art Software-as-a-Service (SaaS) solution.

The Patient Journey module, part of the Patient IntelligenceTM enterprise platform, revolutionizes the way healthcare professionals monitor and manage patient care, offering a comprehensive and holistic approach to tracking each stage of a patient’s healthcare experience. With Azra AI’s advanced technology, healthcare providers can now access a unified platform that provides real-time updates, data-driven insights, and personalized care plans for each patient.

Key Features and Benefits of the Azra AI Patient Journey Module:

Centralized Care Management: Using AI, the Patient Journey module consolidates patient information, medical history, and treatment plans into a single, user-friendly interface. This streamlines communication and collaboration among healthcare professionals, ensuring continuity of care.

Real-Time Updates: Healthcare providers can track a patient’s progress in real-time, receiving instant updates on diagnostic tests, treatment outcomes, and other critical milestones. This allows for timely interventions and personalized care adjustments as needed.

Data-Driven Insights: The module harnesses the power of AI and machine learning to analyze vast amounts of patient data, providing valuable insights into treatment effectiveness, patient adherence, and population health trends. These data points support evidence-based decision-making and drive continuous quality improvement initiatives.

Seamless EHR Integration: Azra AI’s Patient Journey module helps healthcare organizations avoid redundant documentation by fully integrating with any EHR, so clinical staff can spend less time documenting and more time providing patient care.

Navigation Standardization: The Patient Journey module ensures that navigators no longer have to rely on outdated methods for tracking cancer patient care. In one, easy-to-use application, navigators can see in real time how many patients they are actively helping, which tasks to prioritize each day, and which are coming due or are overdue. Every navigator is using the same EHR-integrated application, which means greater cross-coverage, efficiency, and impact.

“We’re excited to introduce the Patient Journey module, as it represents a significant milestone in our mission to use AI to accelerate cancer treatment,” said Chris Cashwell, CEO of Azra AI. “For too long, cancer programs across the U.S. have had to rely on manual processes and outdated methods — like binders, sticky notes, and spreadsheets — to manage the care of cancer patients, because the fields they needed simply didn’t exist in the EHRs. Now, with Patient Journey, that all changes. Not only can navigators, who are critical to the success of cancer patients, have a comprehensive solution to manage a patient’s care, but they can also rest assured that the EHR will be updated — avoiding costly double documentation.”

The Azra AI Patient Journey module is now available in the Azra AI Patient IntelligenceTM enterprise SaaS platform. For more information about the module or to schedule a demonstration, please visit www.azra-ai.com/get-a-demo.

Additional Resources

  • Register and join Dr. Douglas Flora, executive medical director of oncology services at St. Elizabeth Healthcare, Jami DeNigris, director of cancer services at Inspira Health, and Brook Blackmore, vice president of clinical operations at Azra AI for an engaging webinar titled “Harnessing AI for Oncology Service Line Excellence” on August 10, 2023, at 1 p.m. Eastern Daylight Time.
  • Stay at the forefront of healthtech innovation and insights by following Azra AI on LinkedIn for exciting updates and thought-provoking content.

About Azra AI

Azra AI uses proprietary artificial intelligence and machine learning software to quickly identify at-risk patients who need follow-up care, resulting in more equitable health outcomes, increased patient retention, and a reduced burden on clinical workers. This revolutionary technology — used in more than 200 hospitals and cancer centers across the country — accelerates the patient care process and delivers a positive impact on clinical, financial, and operational outcomes. Learn more about Azra AI and the Patient IntelligenceTM platform at www.azra-ai.com.

Contacts

Jason Beck

615-838-0457

jason.beck@azra-ai.com

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago